June 9, 2016
Grünenthal Group, Germany’s family-owned, research-based drug maker, said on June 7 that its supervisory board has appointed Gabriel Baertschi, Japan President of AstraZeneca, as its CEO effective on October 1, 2016. Mr Baertschi will take over the reins from Eric-Paul...read more